Dr. Andreas Jenne
Andreas has launched six biotech companies, which he managed in leading positions. Among others, he was CEO of Kinaxo, a proteomics service provider that was sold to Evotec, and NEO New Oncology, a cancer diagnostics company that was acquired by Siemens Healthcare.
In addition to his entrepreneurial activities, he is a board member in various biotech and medtech companies. Andreas holds a Ph.D. in Chemistry from the Ludwig-Maximilians-University in Munich.